Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAP
SAP
|
+$2.15B |
| 2 |
UBS Group
UBS
|
+$1.53B |
| 3 |
BP
BP
|
+$1.23B |
| 4 |
Spotify
SPOT
|
+$1.13B |
| 5 |
Barclays
BCS
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.73B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.53B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.47B |
| 4 |
Broadcom
AVGO
|
+$2.43B |
| 5 |
Netflix
NFLX
|
+$2.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.26% |
| 2 | Financials | 16.92% |
| 3 | Healthcare | 11.65% |
| 4 | Industrials | 8.55% |
| 5 | Energy | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $7.36M | ﹤0.01% |
159,900
-4,801,652
| -97% | -$237M |
|
452
Viridian Therapeutics
VRDN
$2.67B
| $7.24M | ﹤0.01% |
537,024
+18,997
| +4% | +$324K |
|
453
Columbus McKinnon
CMCO
$584M
| $7.2M | ﹤0.01% |
424,998
+18,030
| +4% | +$468K |
|
454
Nice
NICE
$5.97B
| $7.18M | ﹤0.01% |
46,576
-94,688
| -67% | -$15.1M |
|
455
Chemed
CHE
$7.22B
| $7.07M | ﹤0.01% |
11,483
+3,499
| +44% | +$1.99M |
|
456
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
| $6.93M | ﹤0.01% |
47,484
+30,763
| +184% | +$4.47M |
|
457
Church & Dwight Co
CHD
$24.5B
| $6.88M | ﹤0.01% |
62,458
+7,691
| +14% | +$823K |
|
458
First Industrial Realty Trust
FR
$8.44B
| $6.71M | ﹤0.01% |
124,432
| – | – |
|
459
Extra Space Storage
EXR
$31.6B
| $6.65M | ﹤0.01% |
44,752
-14,685
| -25% | -$2.23M |
|
460
West Pharmaceutical
WST
$24.9B
| $6.56M | ﹤0.01% |
29,321
+579
| +2% | +$160K |
|
461
Revvity
RVTY
$12.8B
| $6.56M | ﹤0.01% |
62,019
+4,771
| +8% | +$550K |
|
|
SFBS
462
ServisFirst Bancshares
SFBS
$4.86B
| $6.53M | ﹤0.01% |
79,082
+73,463
| +1,307% | +$6.38M |
|
463
Colgate-Palmolive
CL
$74.4B
| $6.39M | ﹤0.01% |
68,181
-4,447
| -6% | -$398K |
|
464
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $6.36M | ﹤0.01% |
11,362
+334
| +3% | +$196K |
|
465
Bentley Systems
BSY
$10.6B
| $6.31M | ﹤0.01% |
160,499
+16,242
| +11% | +$725K |
|
466
CVS Health
CVS
$122B
| $6.31M | ﹤0.01% |
93,160
+11,599
| +14% | +$694K |
|
467
Arrowhead Research
ARWR
$12.4B
| $6.16M | ﹤0.01% |
483,253
+340,314
| +238% | +$6.19M |
|
468
Capri Holdings
CPRI
$1.74B
| $6.15M | ﹤0.01% |
+311,654
| New | +$6.9M |
|
469
Vanguard Total Bond Market
BND
$158B
| $6.08M | ﹤0.01% |
82,765
+9,311
| +13% | +$676K |
|
470
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.74B
| $5.96M | ﹤0.01% |
70,509
-31,011
| -31% | -$2.92M |
|
471
Acadia Pharmaceuticals
ACAD
$5.03B
| $5.9M | ﹤0.01% |
355,021
+27,516
| +8% | +$500K |
|
|
XHR
472
Xenia Hotels & Resorts
XHR
$1.79B
| $5.86M | ﹤0.01% |
498,310
+248
| +0% | +$3.45K |
|
473
Crescent Energy
CRGY
$3.82B
| $5.83M | ﹤0.01% |
+518,293
| New | +$7.14M |
|
474
Kimberly-Clark
KMB
$36.5B
| $5.8M | ﹤0.01% |
40,783
-25,558
| -39% | -$3.44M |
|
475
United Therapeutics
UTHR
$23.1B
| $5.73M | ﹤0.01% |
18,589
+2,250
| +14% | +$771K |
|
Similar funds
Ken Fisher's Q1 2025 Portfolio in Review
As of Q1 2025, Ken Fisher held 1,092 positions worth $231B, down 8.1% from $251B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher withdrew a net $11.5B in Q1 2025, closing 93 positions and reducing 435 holdings. Its most notable exit was United Microelectronic, an estimated $47.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ken Fisher opened a new position in Spotify worth $1.12B.
- Ken Fisher's largest Q1 2025 buy was Spotify: 2,028,898 shares worth $1.12B.
- Ken Fisher added most to SAP in Q1 2025, an estimated $2.15B increase.
- Ken Fisher's biggest Q1 2025 reduction was Amazon, cutting an estimated $2.73B.
- Ken Fisher fully exited United Microelectronic in Q1 2025, selling an estimated $47.4M.
- Ken Fisher's ten largest holdings make up 30% of its $231B portfolio in Q1 2025.
- Ken Fisher opened 117 new positions and closed 93 in Q1 2025.
- Ken Fisher's portfolio value fell 8.1% quarter-over-quarter to $231B.
Based on Fisher Asset Management's 13F filing for Q1 2025, filed 14 May 2025.